Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
August 22, 2023, KevinMD
For Orthopedic Surgeons, an All-of-the-Above Approach Lowers Liability Risks
Jacqueline Ross, RN, PhD, Coding Director, and Eric E. Cleckler, MSN, RN, Patient Safety Risk Manager II, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, analyze orthopedic medical malpractice insurance claims and translate the findings into patient safety insights to help medical professionals pursue best practices for risk mitigation.
Mar 07, 2023
In Memoriam: Donald J. Palmisano, MD, JD, FACS
It is with great sadness that we report the passing of long-time Board Member Donald J. Palmisano, MD, JD, FACS.
From
The Doctor’s Advocate
December 01, 2022, Healthcare Risk Management
Remember the Basics of Good Documentation
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, provides suggestions for executing good documentation practices to accurately record patient encounters.
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Jun 05, 2025
The Doctors Company Announces Acquisition of ProAssurance
The Doctors Company has entered into a definitive agreement to acquire ProAssurance, and other company news and insights.
From
The Doctor’s Advocate
Social Inflation Causes Between $2.4 and $3.5 Billion of All Medical Malpractice Losses, The Doctors Company Study Finds
In the decade ending in 2021, between $2.4 and $3.5 billion, or 8 to 11 percent, of all medical malpractice losses incurred by physician-focused insurers stemmed from social inflation, according to new research from The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group.
Jun 05, 2025
Advancing and Protecting Medical Liability Reforms
TDC Group’s recent medical liability advocacy work has seen success nationwide, with opportunities to enact new reforms in some states, while still facing difficult environments in others.
From
The Doctor’s Advocate
Randall Nukk
Randall Nukk is physician niche president for Gallagher Healthcare in Itasca, Illinois. His areas of expertise include medical malpractice insurance and coverage and exposure analysis.
Dec 01, 2022
Industry and Company News
Announcements in the fourth quarter of 2022 include our AM Best ‘A’ (Excellent) Financial Rating, new Leading Voices in Healthcare resources, and a new article exploring technology-enabled healthcare.
From
The Doctor’s Advocate
